Bernie Fernandes, State Manager (WA & SA) of Sequoia Financial Group (ASX:SEQ), talks with CEO and Managing Director Garry Crole. Bernie shares insights for advisors from his long career.
25 Oct 2023 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses efficacy results for the company's glioblastoma therapy.
18 Nov 2021 - Etherstack Limited (ASX:ESK) CEO and Executive Director David Deacon introduces the company's push-to-talk communications technology for essential services.
11 Dec 2020 - Novatti Group Limited (ASX:NOV) Managing Director Peter Cook discusses the company's strategy of partnering with Tier 1 companies, including Ripple, Google Pay and Samsung Pay.
28 Sep 2020 - Cyclopharm Limited (ASX:CYC) Managing Director and CEO James McBrayer provides an update on the company's US Phase 3 trial for Technegas, and USFDA approval process timeline, with commercial sales expected in the US for 2021.
24 Jan 2024 - Investment expert Winston Sammut discusses recent M&A activity in the property sector, analyzing BWP Trust's bid for Newmarket and Aspen's offer for Eureka Holdings. Sammut shares insights on deal rationale, pricing concerns, and potential market implications.
23 Apr 2021 - Capral Limited (ASX:CAA) Managing Director Tony Dragicevich talks about the company's strong FY20 results despite COVID, its product mix, operating environment and outlook.
16 Oct 2024 - Rita Gatt, National Lead Partner - Regulation, Security and Risk at Deloitte, discusses the revolutionary potential of quantum computing.
28 Aug 2019 - Noxopharm Limited (ASX:NOX) CEO Dr Greg van Wyk discusses the company's anti-prostate cancer drug Veyonda, its efficacy in prostate cancer treatment, the drug’s upside and the company’s strategy for growth.
25 Jul 2023 - BluGlass Limited (ASX:BLG) CEO Jim Haden provides an update on the company, discussing customers and market, product improvements, vertical integration and roadmap.
